bis
Market Research Report

A quick peek into the report

Liver Fibrosis Market - A Global and Regional Analysis

Focus on Country and Region - Analysis and Forecast, 2025-2035

 
Some Faq's

Frequently Asked Questions

Ans: The global liver fibrosis market was valued at approximately USD XX billion in 2023 and is projected to reach USD XX billion by 2035, exhibiting a compound annual growth rate (CAGR) of approx. XX% from 2025 to 2035.

Ans: Major players in the global liver fibrosis market include Akero Therapeutics, Sagimet Biosciences, Inventiva Pharma, Novo Nordisk, Viking Therapeutics, Boston Pharmaceuticals, Aligos Therapeutics, Boehringer Ingelheim, and 89bio, among others. 

Trends:
•    Increasing government initiatives and support
•    Increasing development of combination therapies
Driver:
•    Increasing research and development activities by key players
•    Increasing prevalence of liver fibrosis

•    Lack of approved, effective antifibrotic therapies
•    High cost of treatment and drug development 

•    Expansion of the liver fibrosis market into emerging regions
•    Integration of artificial intelligence in the liver fibrosis treatment